Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-4,500
Closed -$9.77K 7141
2024
Q4
$9.77K Hold
4,500
﹤0.01% 5942
2024
Q3
$9.95K Sell
4,500
-500
-10% -$1.1K ﹤0.01% 5800
2024
Q2
$10.1K Buy
5,000
+500
+11% +$1.34K ﹤0.01% 5742
2024
Q1
$10.5K Buy
+4,500
New +$10.7K ﹤0.01% 5747
2019
Q3
Sell
-500
Closed -$1K 6529
2019
Q2
$1K Buy
+500
New +$956 ﹤0.01% 6252
2019
Q1
Sell
-2,500
Closed -$5K 6235
2018
Q4
$5K Buy
+2,500
New +$6.98K ﹤0.01% 6073

Other funds holding IMMP

Wells Fargo's IMMP Position: Q1 2025 in Review

Wells Fargo sold out of Immutep (IMMP) in Q1 2025, closing a stake of 4,500 shares — an estimated $9.77K sold.

Wells Fargo first reported a position in IMMP in Q4 2018 and held it in 6 quarters. The position peaked at $10.5K in Q1 2024. 23 funds tracked by Wall St. Rank hold IMMP as of Q1 2025.

  • Wells Fargo reported no remaining Immutep position as of Q1 2025 after selling out during the quarter.
  • Wells Fargo sold 4,500 Immutep shares in Q1 2025, an estimated $9.77K.
  • Wells Fargo first reported a position in Immutep in Q4 2018 and held it in 6 quarters.
  • Wells Fargo's Immutep position peaked at $10.5K in Q1 2024.
  • 23 funds tracked by Wall St. Rank held Immutep as of Q1 2025.

Based on Wells Fargo's 13F filing for Q1 2025, filed 13 May 2025.